| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,550 | 15,044 | 14,648 | 17,220 | | Cost of Revenue | 5,281 | 5,777 | 5,822 | 6,419 | | | Gross Profit | 9,269 | 9,267 | 8,826 | 10,802 | | | Operating Expenses | | Research Development | 3,305 | 3,077 | 3,743 | 3,540 | | Selling General and Administrative | 6,514 | 6,974 | 7,542 | 8,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (551) | (783) | (2,460) | (938) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 375 | 517 | 166 | 339 | | Earnings Before Interest And Taxes | (176) | (266) | (2,293) | (599) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (176) | (266) | (2,293) | (599) | | Income Tax Expense | 121 | (22) | (879) | (179) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (297) | (244) | (1,414) | (420) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (297) | (244) | (1,414) | (420) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($297) | ($244) | ($1,414) | ($420) |
|
0.01% Nasdaq 
0.01 (0.11%) 
Income Statement
